Götz M. Richter
Director/Board Member at CeloNova BioSciences, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jason Cone | M | - |
CeloNova BioSciences, Inc.
 CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | 10 years |
| Carl J. St. Bernard | M | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | 5 years |
| Mark C. Bates | M | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | - |
| Markus Hecker | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Erich Schlick | M | 72 |
Ruprecht-Karls-Universität Heidelberg
| - |
| Paul Scigalla | M | 79 |
Ruprecht-Karls-Universität Heidelberg
| 32 years |
| Gerd Auffarth | M | 59 |
Ruprecht-Karls-Universität Heidelberg
| 13 years |
| Andreas Wentzensen | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Kathy Conner | F | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | - |
| Robert W. Mason | M | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | 10 years |
| Sara Carlile | F | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | 10 years |
| Eugen Leo | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Ernst Biekert | M | 99 |
Ruprecht-Karls-Universität Heidelberg
| 56 years |
| Michael Heinz | M | 60 |
Ruprecht-Karls-Universität Heidelberg
| 7 years |
| Magnus von Knebel Döberitz | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Harry R. Jacobson | M | 76 |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | - |
| Margret Suckale | F | 68 |
Ruprecht-Karls-Universität Heidelberg
| - |
| Paul Kirchhof | M | - |
Ruprecht-Karls-Universität Heidelberg
| - |
| Thomas Lyles | M | - |
CeloNova BioSciences, Inc.
CeloNova BioSciences, Inc. Medical SpecialtiesHealth Technology CeloNova BioSciences, Inc. develops, manufactures, and markets interventional cardiology and endovascular products. The firm's products are used by physicians across the globe to improve patient outcomes in the fields of vascular intervention and embolization. The company was founded by John D. Feltman in April 2000 and is headquartered in San Antonio, TX. | - |
| Thorlef Spickschen | M | 83 |
Ruprecht-Karls-Universität Heidelberg
| - |
| Uwe Bicker | M | 79 |
Ruprecht-Karls-Universität Heidelberg
| 13 years |
| Mohsen M. Sohi | M | 65 |
Ruprecht-Karls-Universität Heidelberg
| - |
| Malte Bahner | M | 61 |
Ruprecht-Karls-Universität Heidelberg
| - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 15 | 65.22% |
| United States | 8 | 34.78% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Götz M. Richter
- Personal Network
